BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34229290)

  • 1. Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life.
    Camac ER; Voelker H; Criner GJ;
    Respir Med; 2021 Sep; 186():106526. PubMed ID: 34229290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-Term Impact of the Frequency of COPD Exacerbations on Quality of Life.
    Camac ER; Stumpf NA; Voelker HK; Criner GJ
    Chronic Obstr Pulm Dis; 2022 Jul; 9(3):298-308. PubMed ID: 35397199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis.
    Martin AL; Marvel J; Fahrbach K; Cadarette SM; Wilcox TK; Donohue JF
    Respir Res; 2016 Apr; 17():40. PubMed ID: 27084761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation frequency and course of COPD.
    Halpin DM; Decramer M; Celli B; Kesten S; Liu D; Tashkin DP
    Int J Chron Obstruct Pulmon Dis; 2012; 7():653-61. PubMed ID: 23055714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
    Solem CT; Sun SX; Sudharshan L; Macahilig C; Katyal M; Gao X
    Int J Chron Obstruct Pulmon Dis; 2013; 8():641-52. PubMed ID: 24376348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease.
    Hernández Cordero AI; Yang CX; Li X; Milne S; Chen V; Hollander Z; Ng R; Criner GJ; Woodruff PG; Lazarus SC; Connett JE; Han MK; Martinez FJ; Reed RM; Man SFP; Leung JM; Sin DD
    Respir Res; 2021 Dec; 22(1):316. PubMed ID: 34937547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.
    Kim V; Zhao H; Regan E; Han MK; Make BJ; Crapo JD; Jones PW; Curtis JL; Silverman EK; Criner GJ;
    Chest; 2019 Oct; 156(4):685-695. PubMed ID: 31047955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the CAT in the therapy assessment of COPD exacerbations in China.
    Tu YH; Zhang Y; Fei GH
    BMC Pulm Med; 2014 Mar; 14():42. PubMed ID: 24618290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study.
    Miravitlles M; Ferrer M; Pont A; Zalacain R; Alvarez-Sala JL; Masa F; Verea H; Murio C; Ros F; Vidal R;
    Thorax; 2004 May; 59(5):387-95. PubMed ID: 15115864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
    Criner GJ; Connett JE; Aaron SD; Albert RK; Bailey WC; Casaburi R; Cooper JA; Curtis JL; Dransfield MT; Han MK; Make B; Marchetti N; Martinez FJ; Niewoehner DE; Scanlon PD; Sciurba FC; Scharf SM; Sin DD; Voelker H; Washko GR; Woodruff PG; Lazarus SC; ;
    N Engl J Med; 2014 Jun; 370(23):2201-10. PubMed ID: 24836125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbations of Chronic Obstructive Pulmonary Disease and Quality of Life of Patients.
    Rubinsztajn R; Przybyłowski T; Maskey-Warzechowska M; Karwat K; Chazan R
    Adv Exp Med Biol; 2016; 884():69-74. PubMed ID: 26542597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: A meta-analysis.
    Guo J; Chen Y; Zhang W; Tong S; Dong J
    Int J Surg; 2020 Jun; 78():28-35. PubMed ID: 32304896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ.
    Menn P; Weber N; Holle R
    Health Qual Life Outcomes; 2010 Apr; 8():39. PubMed ID: 20398326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in quality of life in patients with COPD.
    Han MK; Curran-Everett D; Dransfield MT; Criner GJ; Zhang L; Murphy JR; Hansel NN; DeMeo DL; Hanania NA; Regan EA; Make BJ; Martinez FJ; Westney GE; Foreman MG;
    Chest; 2011 Nov; 140(5):1169-1176. PubMed ID: 21636665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of hospitalisations for exacerbations of COPD on health-related quality of life.
    Esteban C; Quintana JM; Moraza J; Aburto M; Egurrola M; España PP; Pérez-Izquierdo J; Aguirre U; Aizpiri S; Capelastegui A
    Respir Med; 2009 Aug; 103(8):1201-8. PubMed ID: 19272762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study.
    Wilke S; Janssen DJ; Wouters EF; Schols JM; Franssen FM; Spruit MA
    Health Qual Life Outcomes; 2012 Aug; 10():98. PubMed ID: 22909154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression is a major determinant of both disease-specific and generic health-related quality of life in people with severe COPD.
    Jang SM; Kim KU; Na HJ; Song SE; Lee SH; Lee H; Kim YS; Lee MK; Park HK
    Chron Respir Dis; 2019; 16():1479972318775422. PubMed ID: 29742914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
    Dilektasli AG; Demirdogen Cetinoglu E; Uzaslan E; Budak F; Coskun F; Ursavas A; Ercan I; Ege E
    Int J Chron Obstruct Pulmon Dis; 2017; 12():199-208. PubMed ID: 28115842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial.
    Osadnik CR; McDonald CF; Miller BR; Hill CJ; Tarrant B; Steward R; Chao C; Stodden N; Oliveira CC; Gagliardi N; Holland AE
    Thorax; 2014 Feb; 69(2):137-43. PubMed ID: 24005444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.